These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 821572)

  • 41. INTESTINAL ABSORPTION OF 45CA IN STONE-FORMING PATIENTS.
    CANIGGIA A; GENNARI C; CESARI L
    Br Med J; 1965 Feb; 1(5432):427-9. PubMed ID: 14237927
    [No Abstract]   [Full Text] [Related]  

  • 42. [Morphologic and metabolic studies on the effect of ethane-1-hydroxy-1, 1-diphosphonate (EHDP) on the epiphyseal plate and metaphysis of the rat].
    Katoh Y
    Nihon Seikeigeka Gakkai Zasshi; 1986 May; 60(5):529-45. PubMed ID: 3091743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects.
    Russell RG; Fleisch H
    Clin Orthop Relat Res; 1975 May; (108):241-63. PubMed ID: 166785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the ultrastructure of parathyroid glands and plasma immunoreactive parathyroid hormone in pregnant cows fed a low calcium diet.
    Yarrington JT; Capen CC; Black HE; Re R; Potts JT; Geho WB
    Lab Invest; 1977 Apr; 36(4):402-12. PubMed ID: 191694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dietary fluoride on biomechanical and morphological changes in chick bones.
    Chan MM; Riggins RS; Rucker RB
    J Nutr; 1977 Sep; 107(9):1747-54. PubMed ID: 408470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets.
    Walton RJ; Smith R; Russell RG
    Calcif Tissue Res; 1976 Aug; 21 Suppl():339-43. PubMed ID: 182335
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of ectopic calcification in uremia.
    Zucchelli P; Fusaroli M; Fabbri L; Pavlica P; Casanova S; Viglietta G; Sasdelli M
    Kidney Int Suppl; 1978 Jun; (8):S86-90. PubMed ID: 99599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium absorption in diphosphonate-treated rats: effect of parathyroid function, dietary calcium and phosphorus.
    Bonjour JP; Fleisch H; Trechsel U
    J Physiol; 1977 Jan; 264(1):125-39. PubMed ID: 402471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
    N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract]   [Full Text] [Related]  

  • 51. Biochemistry and radiologic diagnosis of bone disease.
    Saville PD
    Radiol Clin North Am; 1970 Aug; 8(2):207-14. PubMed ID: 4247690
    [No Abstract]   [Full Text] [Related]  

  • 52. Chronic intoxication by ethane-1-hydroxy-1,1-diphosphonate (EHDP) in a child with myositis ossificans progressiva.
    Pazzaglia UE; Beluffi G; Ravelli A; Zatti G; Martini A
    Pediatr Radiol; 1993; 23(6):459-62. PubMed ID: 8255652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [HYPERCALCEMIA SYNDROMES].
    UEHLINGER E
    Munch Med Wochenschr; 1964 Apr; 106():692-701. PubMed ID: 14197291
    [No Abstract]   [Full Text] [Related]  

  • 54. [Inhibitory action of diphosphonate on the development of pancreatic concrements (experiment with EHDP (author's transl)].
    Klemm G; Putzke HP
    Dtsch Z Verdau Stoffwechselkr; 1981; 41(3):128-34. PubMed ID: 6790262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of diphosphonate on calcium phosphate crystallization in urine in vitro.
    Oata M; Pak CY
    Kidney Int; 1973 Dec; 4(6):401-6. PubMed ID: 4205283
    [No Abstract]   [Full Text] [Related]  

  • 56. Hyperparathyroidism in childhood. A case followed up for 15 years.
    Gerlóczy F; Haranghy L; Hedri E; Barta L; Gefferth K; Reichard J; Molnár M
    Acta Paediatr Acad Sci Hung; 1970; 11(1):11-23. PubMed ID: 5528259
    [No Abstract]   [Full Text] [Related]  

  • 57. Parathyroid hormone effects in rats treated with diphosphonate.
    Talmage RV; Anderson JJ
    Science; 1974 Feb; 183(4125):661-3. PubMed ID: 4204000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.
    Basle MF; Rebel A; Renier JC; Audran M; Filmon R; Malkani K
    Clin Orthop Relat Res; 1984 Apr; (184):281-8. PubMed ID: 6423333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative bone histology in 38 patients with advanced renal failure.
    Eastwood JB
    J Clin Pathol; 1982 Feb; 35(2):125-34. PubMed ID: 7068905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors affecting uptake and retention of technetium-99m-diphosphonate and 99m-pertechnetate in osseous, connective and soft tissues.
    Francis MD; Slough CL; Tofe AJ
    Calcif Tissue Res; 1976 Jun; 20(3):303-11. PubMed ID: 182328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.